Genetic Engineering & Biotechnology News (GEN)
Touching Base
Touching Base is the dynamic podcast series from the editors of GEN ( Genetic Engineering & Biotechnology News ). Each episode features a rotating cast of senior editors including John Sterling, Kevin Davies, Julianna LeMieux, Alex Philippidis, Uduak Thomas, Corinna Singleman and Fay Lin who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next. Hosted on Acast. See acast.com/privacy for more information.
N'hésitez pas à visiter le site du podcast et à soutenir son créateur : shows.acast.com
Auteur
Genetic Engineering & Biotechnology News (GEN)
Catégorie
Site du podcast
Dernier épisode
13 août 2026
Où écouter ?
Les podcasts dans l'appli Replaio Radio Bientôt disponibleLes podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts
Installe-la gratuitement
Android près de 10 M de téléchargements · note de 4,8
iOS bientôt
Épisodes
Restoring Hearing Loss, CAR T Manufacturing, DNA-Based Medicines, Nvidia and Recursion; Eric Topol 26.01.2024 44:55
Episode 6 (January 26, 2024): 11-year-old regains hearing after gene therapy; Kyverna uses blood draw instead of apheresis for CAR T manufacturing; DNA production technology with GSK and Elegen, StockWatch with Nvidia and Recursion; an interview with renowned cardiologist, Eric Topol, MD Listed below are key references to the GEN stories, media and other items discussed in this episode...
Alzheimer’s Disease, Monkey Cloning, Cytokinetics Stock; Jen Nwankwo 18.01.2024 37:45
Episode 5 (January 19, 2024); RNAs to address Alzheimer’s disease; monkey cloned via somatic cell nuclear transfer; Cytokinetics stock roller coaster; an interview with founder and CEO of 1910 Genetics, Jen Nwankwo, PhD. Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base : · Alzheimer’s Disease Linked to Toxic Short RNAs GEN ,...
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio 11.01.2024 43:49
Episode 4 (January 12, 2024): Takeaways from the J.P. Morgan Health Care conference: Illumina, Danaher, 10x, Empress Therapeutics; an interview with Liberate Bio’s Shawn Davis and Walter Strapps. Listed below are references to relevant GEN stories discussed in this episode of Touching Base : JPM: Illumina’s new CEO spells out 2024 priorities, presents preliminary Q4 2023 results ...
Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis 05.01.2024 38:18
Episode 3 (January 5, 2024): Interview with Co-founder and CEO of Moonwalk Biosciences and former CTO of Illumina, Alex Aravanis; Neuro gene therapy with Novartis and Voyager; GEN reporters look forward to the 2024 J.P. Morgan Healthcare Conference Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base : Novartis, Voyager Ink Up-to-$1.3...
Launch of Tome Biosciences, AI scientist, mRNA vaccines 21.12.2023 38:10
Episode 2 (December 22, 2023): Interview with President and CEO of Tome Biosciences, Rahul Kakkar; intelligent lab partner using LLMs; AI for antimicrobials; mRNA vaccine production in Africa; Moderna’s positive cancer vaccine data. Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base : The Next Chapter in Genome Editing? Tome Emerges...
Autism, AI and Epigenetics; Nevan Krogan 08.12.2023 51:30
Episode 1 (Week ending December 8, 2023): Nevan Krogan (UCSF) mapping autism pathways; Nvidia’s latest AI partnership; CAR-T regulations; epigenome editing; mRNA therapeutics. References to the GEN stories, media and other items discussed in this episode of Touching Base : · Autism’s Molecular Mechanisms Uncovered through Protein-Protein Interaction...
Podcasts similaires
Écoute le podcast Touching Base sur Replaio
La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement
Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics
